Cargando…

A CONTROVERSY: WARFARIN FAILURE IN COVID-19 WITH SUPRATHERAPEUTIC INR

Detalles Bibliográficos
Autor principal:	Ur Rahman, Saad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Cardiology Foundation. Published by Elsevier Inc. 2023
Materias:	Complex Clinical Cases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982919/ http://dx.doi.org/10.1016/S0735-1097(23)03821-4

Ejemplares similares

Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study
por: Kawai, Mayumi, et al.
Publicado: (2019)

Extensive Upper Airway Hematoma Secondary to Supratherapeutic Warfarin Anticoagulation
por: Oyedokun, Taofiq Olusegun, et al.
Publicado: (2020)

Warfarin/herbal drink interaction: Elevated INR: case report
Publicado: (2021)

Phlegmasia cerulea dolens associated with acute coronavirus disease 2019 pneumonia despite supratherapeutic warfarin anticoagulation
por: Chun, Tristen T., et al.
Publicado: (2020)

EVOLOCUMAB TREATMENT FAILURE FOLLOWING COVID-19 MRNA VACCINATION
por: Park, Byung Joon, et al.
Publicado: (2022)

Supratherapeutic International Normalized Ratio causing Nephropathy: A Rare Adverse Effect of Warfarin
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2019)

A CASE OF HEART FAILURE WITH REDUCED EJECTION FRACTION DUE TO MYOCARDITIS: A COMPLICATION OF COVID-19 AND LONG-COVID-19 SYNDROME.
por: Al Tamimi, Raad, et al.
Publicado: (2023)

NEW-ONSET HEART FAILURE WITH REDUCED EJECTION FRACTION IN PATIENTS WITH COVID-19
por: Rai, Nanak S., et al.
Publicado: (2023)

ACUTE TRANSCATHETER AORTIC VALVE REPLACEMENT FAILURE SECONDARY TO COVID-19 INFECTION
por: Tacon, Phillip, et al.
Publicado: (2023)

Enoxaparin-sodium/heparin/warfarin: Heparin-induced thrombocytopenia and elevated INR: case report
Publicado: (2021)

ACUTE MYOCARDITIS AND ACUTE DECOMPENSATED HEART FAILURE WITH REDUCED EJECTION FRACTION IN COVID-19
por: Choudhary, Khushal, et al.
Publicado: (2021)

ATRIAL SEPTOSTOMY USED TO TREAT ACUTE RIGHT HEART FAILURE IN COVID-19 PATIENT ON ECMO
por: Gudipati, Swapna, et al.
Publicado: (2022)

AORTIC VALVE ENDOCARDITIS AS A COMPLICATION OF TOCILIZUMAB TREATMENT IN COVID 19 PATIENT
por: Ashraf, Shoaib, et al.
Publicado: (2021)

Predictors for INR-control in a well-managed warfarin treatment setting
por: Björck, Fredrik, et al.
Publicado: (2018)

MULTI-DISCIPLINARY COLLABORATION TO MANAGE END-STAGE HEART FAILURE DURING COVID-19 IN A RURAL COMMUNITY
por: Estes, Bailey, et al.
Publicado: (2021)

MYOPERICARDITIS AND HEART FAILURE WITH REDUCED EJECTION FRACTION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE
por: Cole, Molly, et al.
Publicado: (2023)

PARADOXICAL EMBOLIC ACUTE MCA STROKE IN COVID-19 RELATED SUBMASSIVE PULMONARY EMBOLISM
por: Jasti, Jaswanth, et al.
Publicado: (2023)

Warfarin dose and INR related to genotypes of CYP2C9 and VKORC1 in patients with myocardial infarction
por: Haug, Kari Bente Foss, et al.
Publicado: (2008)

Effects of changing the timing of warfarin administration in combination with fluconazole on prolongation of the PT-INR: a case report
por: Akamatsu, Hayato, et al.
Publicado: (2023)

A case of successful concomitant administration of warfarin and uracil‐tegafur/leucovorin achieved by self‐measurement of INR
por: Watanabe, Norio, et al.
Publicado: (2017)

Pillbox Use and INR Stability in a Prospective Cohort of New Warfarin Users
por: Dumas, Stephanie, et al.
Publicado: (2016)

Optimal INR level for warfarin therapy after mechanical mitral valve replacement
por: Kamthornthanakarn, Itthidet, et al.
Publicado: (2019)

Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
por: Eljilany, Islam, et al.
Publicado: (2021)

HYPOFIBRINOGENEMIA IN A PATIENT WITH CARDIOGENIC SHOCK, LEFT VENTRICULAR (LV) THROMBUS, COVID-19, AND SEVERE LIVER INJURY: A CASE REPORT OF COMPLEX DECISION MAKING IN THE SETTING OF MULTIORGAN FAILURE WITH UNCLEAR CAUSALITY
por: Mariam, Alaha, et al.
Publicado: (2023)

Spontaneous Epiglottic Hematoma Secondary to Supratherapeutic Anticoagulation
por: Koch, Cody A., et al.
Publicado: (2010)

Extending INR testing intervals in warfarin patients at a multi-center anticoagulation clinic
por: Papala, Michelle, et al.
Publicado: (2021)

MYOCARDITIS FROM COVID-19
por: Chittal, Abhinandan, et al.
Publicado: (2022)

BAFFLING BRADYCARDIA AND COVID-19
por: Rehman, Karim Abdur, et al.
Publicado: (2022)

POST-COVID-19 HYPERTENSION IN A TEENAGER
por: Tadeo, Danilo, et al.
Publicado: (2023)

UREMIC PERICARDITIS IN A COVID-19 PATIENT
por: Sherif, Khaled, et al.
Publicado: (2021)

STEMI IN COVID-19: NOT ALWAYS A MIMIC!
por: Vinnakota, Shravya, et al.
Publicado: (2022)

Determining INR Awareness of the Patients who Use Warfarin and Rates of Achieving the Target Dosage
por: Demir, Nazan, et al.
Publicado: (2020)

ARE MILD COVID-19 SYMPTOMS REALLY BENIGN? IDENTIFICATION OF SUBCLINICAL MYOCARDITIS IN A TEEN WITH REMOTE, MILD COVID-19 INFECTION
por: Rye-Buckingham, Summer, et al.
Publicado: (2022)

NONBACTERIAL THROMBOTIC ENDOCARDITIS IN A COVID-19 PATIENT
por: Ahmad, Ali, et al.
Publicado: (2023)

COVID-19 AND RECURRENT ST ELEVATION
por: Fohle, Emmanuel, et al.
Publicado: (2021)

VIRAL MYOCARDITIS IN THE COVID-19 PANDEMIC
por: Banbury, Zachary, et al.
Publicado: (2021)

COVID-19 INFECTION MANIFESTING AS STEMI
por: La, Van, et al.
Publicado: (2021)

COVID-19 PRESENTING WITH MYOCARDIAL INFARCTION
por: Ismayl, Mahmoud, et al.
Publicado: (2022)

FULMINANT MYOCARDITIS-A UNIQUE COMPLICATION OF COVID-19
por: Ahmed, Anas, et al.
Publicado: (2021)

SEVERE TAKOTSUBO CARDIOMYOPATHY IN A PATIENT WITH COVID-19
por: Satija, Vaibhav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o0rgk5gq52bn7f4euiqdaju6sn